An experimental COVID-19 vaccine being developed at Oxford by AstraZeneca received a big order: $1.2 billion from the United States for 300 million doses.
US pledges $1.2 billion to access 300 million doses of experimental COVID-19 vaccine
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over